Legha SS - Search Results

1

Adriamycin and mitomycin C: possible synergistic cardiotoxicity.

Buzdar AU, Legha SS, Tashima CK, Hortobagyi GN, Yap HY, Krutchik AN, Luna MA, Blumenschein GR. Buzdar AU, et al. Among authors: legha ss. Cancer Treat Rep. 1978 Jul;62(7):1005-8. Cancer Treat Rep. 1978. PMID: 688243

2

Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer.

Legha SS, Blumenschein GR, Buzdar AU, Hortobagyi GN, Bodey GP. Legha SS, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1961-4. Cancer Treat Rep. 1979. PMID: 526929

3

Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.

Legha SS, Ajani JA, Blumenschein GR, Hortobagyi GN, Buzdar AU. Legha SS, et al. Cancer. 1984 May 1;53(9):1836-40. doi: 10.1002/1097-0142(19840501)53:9<1836::aid-cncr2820530906>3.0.co;2-p. Cancer. 1984. PMID: 6231092

4

Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine.

Hortobagyi GN, Yap HY, Wiseman CL, Blumenschein GR, Buzdar AU, Legha SS, Gutterman JU, Hersh EM, Bodey GP. Hortobagyi GN, et al. Among authors: legha ss. Cancer Treat Rep. 1980 Jan;64(1):157-9. Cancer Treat Rep. 1980. PMID: 6991103 Clinical Trial.

5

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens.

Buzdar AU, Legha SS, Hortobagyi GN, Yap HY, Wiseman CL, Distefano A, Schell FC, Barnes BC, Campos LT, Blumenschein GR. Buzdar AU, et al. Among authors: legha ss. Cancer. 1981 Jun 15;47(12):2798-802. doi: 10.1002/1097-0142(19810615)47:12<2798::aid-cncr2820471207>3.0.co;2-t. Cancer. 1981. PMID: 7260870

6

Pulmonary toxicity of mitomycin.

Buzdar AU, Legha SS, Luna MA, Tashima CK, Hortobagyi GN, Blumenschein GR. Buzdar AU, et al. Among authors: legha ss. Cancer. 1980 Jan 15;45(2):236-44. doi: 10.1002/1097-0142(19800115)45:2<236::aid-cncr2820450207>3.0.co;2-0. Cancer. 1980. PMID: 7351010

7

Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma.

Legha SS, Buzdar AU, Hortobagyi GN, DiStefano A, Wiseman CL, Yap HY, Blumenschein GR, Bodey GP. Legha SS, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2053-6. Cancer Treat Rep. 1979. PMID: 118805 Clinical Trial.

8

Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.

Buzdar AU, Legha SS, Tashima CK, Yap HY, Hortobagyi GN, Hersh EM, Blumenschein GR, Bodey GP. Buzdar AU, et al. Among authors: legha ss. Cancer Treat Rep. 1979 Jan;63(1):115-20. Cancer Treat Rep. 1979. PMID: 369682 Clinical Trial.

9

Prognostic factors in metastatic breast cancer treated with combination chemotherapy.

Swenerton KD, Legha SS, Smith T, Hortobagyi GN, Gehan EA, Yap HY, Gutterman JU, Blumenschein GR. Swenerton KD, et al. Among authors: legha ss. Cancer Res. 1979 May;39(5):1552-62. Cancer Res. 1979. PMID: 427797

10

Drug-associated cardiotoxicity.

Buzdar AU, Legha SS, Hortobagyi GN, Blumenschein GR. Buzdar AU, et al. Among authors: legha ss. JAMA. 1979 May 4;241(18):1893. JAMA. 1979. PMID: 430767 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page